Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Heart Test Laboratories, Inc. ( (HSCS) ) has issued an announcement.
On June 27, 2025, HeartSciences Inc. amended its Bylaws in response to changes in the Texas Business Organizations Code. These amendments include a jury trial waiver for internal entity claims, an ownership threshold for shareholders to initiate derivative proceedings, and clarifications to the exclusive forum provision. The changes aim to align with Texas law and took effect immediately.
The most recent analyst rating on (HSCS) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Heart Test Laboratories, Inc. stock, see the HSCS Stock Forecast page.
Spark’s Take on HSCS Stock
According to Spark, TipRanks’ AI Analyst, HSCS is a Neutral.
The overall score is primarily influenced by the company’s significant financial challenges, which are a major risk factor. However, the stock’s technical momentum and the recent strategic patent grant provide some positive offsetting factors. The lack of earnings call data limits further insights into company guidance and sentiment.
To see Spark’s full report on HSCS stock, click here.
More about Heart Test Laboratories, Inc.
Average Trading Volume: 35,120
Technical Sentiment Signal: Sell
Current Market Cap: $3.96M
For a thorough assessment of HSCS stock, go to TipRanks’ Stock Analysis page.